TIME BioVentures is a Los Angeles-based venture capital firm focused on healthcare and life sciences, with a particular emphasis on Series A investing. It covers therapeutics, diagnostics, tools, devices, and care delivery, making it broad within healthcare but still clinically grounded. Its stage focus makes it particularly relevant to companies transitioning from seed into more structured institutional financing.

Its investment in Phantom Neuro demonstrates real interest in neurotechnology, especially where BCI and prosthetics intersect with medical device development. TIME BioVentures is not exclusively neuro-focused, but it is clearly willing to participate in neurotech opportunities with strong healthcare relevance. Its broader healthcare scope also makes it potentially valuable for companies bridging devices, research, and delivery models.

The firm invests primarily in the United States. For neurotech founders, it is most relevant around Series A when the company has moved beyond concept and begun generating meaningful technical or clinical traction. It is a useful healthcare investor with demonstrated neurotech interest rather than a narrow specialist.